In vitro cellular immune responses to recombinant antigens of Mycobacterium avium subsp. paratuberculosis

Infection and Immunity

Volumn 73, Issue 8, 2005, Pages 5074-5085

  Shin, Sung Jae ^a,b   Chang, Chao Fu ^a,c   Chang, Ching Dong ^a   McDonough, Sean P ^a   Thompson, Belinda ^a   Yoo, Han Sang ^b   Chang, Yung Fu ^a  

^a Department of Obstetrics Gynecology   (United States)

^b Seoul National University   (South Korea)

^c Chung Tai College of Medical Technology   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3D RECEPTOR; COMPLEMENTARY DNA; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; MYCOBACTERIUM ANTIGEN; RECOMBINANT ANTIGEN; RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BOVIDS; CATTLE DISEASE; CELLULAR IMMUNITY; CHRONIC GRANULOMATOUS DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA SYNTHESIS; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MYCOBACTERIUM AVIUM; NONHUMAN; NUCLEOTIDE SEQUENCE; PARATUBERCULOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ANIMALS; ANTIGENS, BACTERIAL; CATTLE; CELL PROLIFERATION; CYTOKINES; FEMALE; IMMUNITY, CELLULAR; LYMPHOCYTE SUBSETS; LYMPHOCYTES; MYCOBACTERIUM PARATUBERCULOSIS; RECOMBINANT PROTEINS; RNA, MESSENGER;

EID: 23344446665     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.8.5074-5085.2005     Document Type: Article

References (56)

1. Adams, J. L., M. T. Collins, and C. J. Czuprynski. 1996. Polymerase chain reaction analysis of TNF-alpha and IL-6 mRNA levels in whole blood from cattle naturally or experimentally infected with Mycobacterium paratuberculosis. Can. J. Vet. Res. 60:257-262.
2. Bannantine, J. P., J. F. Huntley, E. Miltner, J. R. Stabel, and L. E. Bermudez. 2003. The Mycobacterium avium subsp. paratuberculosis 35 kDa protein plays a role in invasion of bovine epithelial cells. Microbiology 149:2061-2069.
3. Begara-McGorura, I., L. A. Wildblood, C. J. Clarke, K. M. Connor, K. Stevenson, C. J. McInnes, J. M. Sharp, and D. G. Jones. 1998. Early immunopathological events in experimental ovine paratuberculosis. Vet. Immunol. Immunopathol. 63:265-287.
4. Brandt, L., M. Elhay, I. Rosenkrands, E. B. Lindblad, and P. Andersen. 2000. ESAT-6 subunit vaccination against Mycobacterium tuberculosis. Infect. Immun. 68:791-795.
5. Brodersen, R., F. Bijlsma, K. Gori, K. T. Jensen, W. Chen, J. Dominguez, K. Haverson, P. F. Moore, A. Saalmuller, D. Sachs, W. J. Slierendrecht, C. Stokes, O. Vainio, F. Zuckermann, and B. Aasted. 1998. Analysis of the immunological cross reactivities of 213 well characterized monoclonal antibodies with specificities against various leucocyte surface antigens of human and 11 animal species. Vet. Immunol. Immunopathol. 64:1-13.
6. Caruso, A. M., N. Serbina, E. Klein, K. Triebold, B. R. Bloom, and J. L. Flynn. 1999. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. J. Immunol. 162:5407-5416.
7. Chan, J., and S. H. Kaufmann. 1994. Immune mechanisms of protection. American Society for Microbiology, Washington, D.C.
8. Chiodini, R. J., and W. C. Davis. 1992. The cellular immunology of bovine paratuberculosis: the predominant response is mediated by cytotoxic gamma/delta T lymphocytes which prevent CD4+ activity. Microb. Pathog. 13:447-463.
9. Coler, R. N., A. Campos-Neto, P. Ovendale, F. H. Day, S. P. Fling, L. Zhu, N. Serbina, J. L. Flynn, S. G. Reed, and M. R. Alderson. 2001. Vaccination with the T cell antigen Mtb 8.4 protects against challenge with Mycobacterium tuberculosis. J. Immunol. 166:6227-6235.
10. Coler, R. N., Y. A. Skeiky, T. Vedvick, T. Bement, P. Ovendale, A. Campos-Neto, M. R. Alderson, and S. G. Reed. 1998. Molecular cloning and immunologic reactivity of a novel low molecular mass antigen of Mycobacterium tuberculosis. J. Immunol. 161:2356-2364.
11. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, and I. M. Orme. 1993. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp. Med. 178:2243-2247.
12. Denis, O., A. Tanghe, K. Palfliet, F. Jurion, T.-P. van den Berg, A. Vanonckelen, J. Ooms, E. Saman, J. B. Ulmer, J. Content, and K. Huygen. 1998. Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection. Infect. Immun. 66: 1527-1533.
13. Dheenadhayalan, V., K. S. Shin, C. F. Chang, C. D. Chang, S. J. Wang, S. McDonough, P. McDonough, S. Stehman, S. Shin, A. Torres, and Y. F. Chang. 2002. Cloning and characterization of the genes coding for antigen 85A, 85B and 85C of Mycobacterium avium subsp. paratuberculosis. DNA Scq. 13:287-294.
14. D'Souza, S., O. Denis, T. Scorza, F. Nzabintwali, H. Verschueren, and K. Huygen. 2000. CD4+ T cells contain Mycobacterium tuberculosis infection in the absence of CD8+ T cells in mice vaccinated with DNA encoding Ag85A. Eur. J. Immunol. 30:2455-2459.
15. Flynn, J. L. 2004. Immunology of tuberculosis and implications in vaccine development. Tuberculosis 84:93-101.
16. Flynn, J. L., and J. Chan. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19:93-129.
17. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249-2254.
18. Geluk, A., K. E. van Meijgaarden, K. L. Franken, J. W. Drijfhout, S. D'Souza, A. Necker, K. Huygen, and T. H. Ottenhoff. 2000. Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8(+) T cells in HLA-transgenic mice and humans. J. Immunol. 165:6463-6471.
19. Harris, N. B., and R. G. Barletta. 2001. Mycobacterium avium subsp. paratuberculosis in veterinary medicine. Clin. Microbiol. Rev. 14:489-512.
20. Harth, G., B.-Y. Lee, J. Wang, D. L. Clemens, and M. A. Horwitz. 1996. Novel insights into the genetics, biochemistry, and immunocytochemistry of the 30-kilodalton major extracellular protein of Mycobacterium tuberculosis. Infect. Immun. 64:3038-3047.
21. Jouanguy, E., F. Altare, S. Lamhamedi, P. Revy, J. F. Emile, M. Newport, M. Levin, S. Blanche, E. Seboun, A. Fischer, and J. L. Casanova. 1996. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N. Engl. J. Med. 335:1956-1961.
22. Jouanguy, E., S. Lamhamedi-Cherradi, D. Lammas, S. E. Dorman, M. C. Fondaneche, S. Dupuis, R. Doffinger, F. Altare, J. Girdlestone, J. F. Emile, H. Ducoulombier, D. Edgar, J. Clarke, V. A. Oxelius, M. Brai, V. Novelli, K. Heyne, A. Fischer, S. M. Holland, D. S. Kumararatne, R. D. Schreiber, and J. L. Casanova. 1999. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat. Genet. 21:370-378.
23. Kamath, A. T., C. G. Feng, M. Macdonald, H. Briscoe, and W. J. Britton. 1999. Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis. Infect. Immun. 67:1702-1707.
24. + γδ T cells. Infect. Immun. 70:1488-1500.
25. + T cells, increased frequency of γδ T cells, and related changes in T-cell function. Infect. Immun. 70:3856-3864.
26. Kormendy, B. 1992. Paratuberculosis vaccine in a large dairy herd. Acta Vet. Hung. 40:171-184.
27. Larsen, A. B., R. S. Merkal, and R. C. Cutlip. 1975. Age of cattle as related to resistance to infection with Mycobacterium paratuberculosis. Am. J. Vet. Res. 36:255-257.
28. Larsen, A. B., A. I. Moyle, and E. M. Himes. 1978. Experimental vaccination of cattle against paratuberculosis (Johne's disease) with killed bacterial vaccines: a controlled field study. Am. J. Vet. Res. 39:65-69.
29. Lim, J.-H., J.-K. Park, E.-K. Jo, C.-H. Song, D. Min, Y.-J. Song, and H.-J. Kim. 1999. Purification and immunoreactivity of three components from the 30/32-kilodalton antigen 85 complex in Mycobacterium tuberculosis. Infect. Immun. 67:6187-6190.
30. Lozes, E., K. Huygen, J. Content, O. Denis, D. L. Montgomery, A. M. Yawman, P. Vandenbussche, J. P. Van Vooren, A. Drowart, J. B. Ulmer, and M. A. Liu. 1997. Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex. Vaccine 15: 830-833.
31. Mak, T. W., and D. A. Ferrick. 1998. The gammadelta T-cell bridge: linking innate and acquired immunity. Nat. Med. 4:764-765.
32. Mollenkopf, H. J., L. Grode, J. Mattow, M. Stein, P. Mann, B. Knapp, J. Ulmer, and S. H. Kaufmann. 2004. Application of mycobacterial proteomics to vaccine design: improved protection by Mycobacterium bovis BCG prime-Rv3407 DNA boost vaccination against tuberculosis. Infect. Immun. 72: 6471-6479.
33. Mollenkopf, H. J., D. Groine-Triebkorn, P. Andersen, J. Hess, and S. H. Kaufmann. 2001. Protective efficacy against tuberculosis of ESAT-6 secreted by a live Salmonella typhimurium vaccine carrier strain and expressed by naked DNA. Vaccine 19:4028-4035.
34. Mullerad, J., A. H. Hovav, Y. Fishman, R. G. Barletta, and H. Bercovier. 2002. Antigenicity of Mycobacterium paratuberculosis superoxide dismutase in mice. FEMS Immunol. Med. Microbiol. 34:81-88.
35. Mullerad, J., I. Michal, Y. Fishman, A. H. Hovav, R. G. Barletta, and H. Bercovier. 2002. The immunogenicity of Mycobacterium paratuberculosis 85B antigen. Med. Microbiol. Immunol. (Berlin) 190:179-187.
36. Naito, M., M. Matsuoka, N. Ohara, H. Nomaguchi, and T. Yamada. 1999. The antigen 85 complex vaccine against experimental Mycobacterium leprae infection in mice. Vaccine 18:795-798.
37. Newport, M. J., C. M. Huxley, S. Huston, C. M. Hawrylowicz, B. A. Oostra, R. Williamson, and M. Levin. 1996. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335:1941-1949.
38. Parra, M., T. Pickett, G. Delogu, V. Dheenadhayalan, A. S. Debrie, C. Locht, and M. J. Brennan. 2004. The mycobacterial heparin-binding hemagglutinin is a protective antigen in the mouse aerosol challenge model of tuberculosis. Infect. Immun. 72:6799-6805.
39. Patterson, C. J., M. LaVenture, S. S. Hurley, and J. P. Davis. 1988. Accidental self-inoculation with Mycobacterium paratuberculosis bacterin (Johne's bacterin) by veterinarians in Wisconsin. J. Am. Vet. Med. Assoc. 192:1197-1199.
40. Rhodes, S. G., R. G. Hewinson, and H. M. Vordermeier. 2001. Antigen recognition and immunomodulation by gamma delta T cells in bovine tuberculosis. J. Immunol. 166:5604-5610.
41. + T cells participate in the memory immune response to Mycobacterium tuberculosis. Infect. Immun. 69:4320-4328.
42. + T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice. Infect. Immun. 67:3980-3988.
43. Serhina, N. V., C. C. Liu, C. A. Scanga, and J. L. Flynn. 2000. CD8+ CTL from lungs of Mycobacterium tuberculosis-infected mice express perform in vivo and lyse infected macrophages. J. Immunol. 165:353-363.
44. Shin, S. J., Y. F. Chang, C. Huang, J. Zhu, L. Huang, H. S. Yoo, K. S. Shin, S. Stehman, and A. Torres. 2004. Development of a polymerase chain reaction test to confirm Mycobacterium avium subsp. paratuberculosis in culture. J. Vet. Diagn. Investig. 16:116-120.
45. Shin, S. J., H. S. Yoo, S. P. McDonough, and Y. F. Chang. 2004. Comparative antibody response of five recombinant antigens in related to bacterial shedding levels and development of serological diagnosis based on 35 kDa antigen for Mycobacterium avium subsp. paratuberculosis. J. Vet. Sci. 5:111-117.
46. Skeiky, Y. A., M. R. Alderson, P. J. Ovendale, J. A. Guderian, L. Brandt, D. C. Dillon, A. Campos-Neto, Y. Lobet, W. Dalemans, I. M. Orme, and S. G. Reed. 2004. Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein. J. Immunol. 172:7618-7628.
47. Skeiky, Y. A., P. J. Ovendale, S. Jen, M. R. Alderson, D. C. Dillon, S. Smith, C. B. Wilson, I. M. Orme, S. G. Reed, and A. Campos-Neto. 2000. T cell expression cloning of a Mycobacterium tuberculosis gene encoding a protective antigen associated with the early control of infection. J. Immunol. 165: 7140-7149.
48. Stabel, J. R. 1996. Production of gamma-interferon by peripheral blood mononuclear cells: an important diagnostic tool for detection of subclinical paratuberculosis. J. Vet. Diagn. Investig. 8:345-350.
49. Stabel, J. R. 2000. Transitions in immune responses to Mycobacterium paratuberculosis. Vet. Microbiol. 77:465-473.
50. Sweeney, R. W. 1996. Transmission of paratuberculosis. Vet. Clin. N. Am. Food Anim. Pract. 12:305-312.
51. Sweeney, R. W., D. E. Jones, P. Habecker, and P. Scott. 1998. Interferon-gamma and interleukin 4 gene expression in cows infected with Mycobacterium paratuberculosis. Am. J. Vet. Res. 59:842-847.
52. Sweeney, R. W., R. H. Whitlock, and A. E. Rosenberger. 1992. Mycobacterium paratuberculosis isolated from fetuses of infected cows not manifesting signs of the disease. Am. J. Vet. Res. 53:477-480.
53. Tanghe, A., J. Content, J.-P. Van Vooren, F. Portaels, and K. Huygen. 2001. Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer. Infect. Immun. 69:5403-5411.
54. Tanghe, A., O. Denis, B. Lambrecht, V. Motte, T. van den Berg, and K. Huygen. 2000. Tuberculosis DNA vaccine encoding Ag85A is immunogenic and protective when administered by intramuscular needle injection but not by epidermal gene gun bombardment. Infect. Immun. 68:3854-3860.
55. Tanghe, A., P. Lefevre, O. Denis, S. D'Souza, M. Braibant, E. Lozes, M. Singh, D. Montgomery, J. Content, and K. Huygen. 1999. Immunogenicity and protective efficacy of tuberculosis DNA vaccines encoding putative phosphate transport receptors. J. Immunol. 162:1113-1119.
56. Wells, S. J., and B. A. Wagner. 2000. Herd-level risk factors for infection with Mycobacterium paratuberculosis in US dairies and association between familiarity of the herd manager with the disease or prior diagnosis of the disease in that herd and use of preventive measures. J. Am. Vet. Med. Assoc. 216:1450-1457.